SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-017422
Filing Date
2019-06-19
Accepted
2019-06-19 16:18:28
Documents
1
Period of Report
2019-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4225
  Complete submission text file 0000899243-19-017422.txt   5691
Mailing Address 33 PHEASANT LANE GREENWICH CT 06830
Business Address
MCGIRR DAVID W J (Reporting) CIK: 0001219023 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 19906241

Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences